Loeb & Loeb partner Mark Waddell is quoted on common pharmaceutical techniques addressing the problem of slow dissolution of pharmaceuticals. This article discusses the claims that the Patent Trial and Appeal Board invalidated patents covering a compound in two of Eli Lilly and Co.’s drugs.
-
Co-Chair, Life Sciences; Chair, Patent Litigation & Counseling